Trxade Group to Present at March Investor Conferences saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Share this article
BOSTON, March 5, 2021 /PRNewswire/
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that Company management will participate in the upcoming H.C. Wainwright Global Life Sciences Conference taking place virtually from March 9-10, 2021.
Akash Bakshi, Senior Vice President and Chief Operating Officer of NeuroBo and Seth Reno, Commercial Advisor of NeuroBo, will present a corporate overview at the conference, including an update on the status of the ongoing phase 2/3 study of lead program, ANA001, in moderate and severe COVID-19 patients.
The presentation will be available beginning March 9, at 7:00 am ET. A webcast of the presentation will be available on the Events and Presentations section of NeuroBo s website at: neurobopharma.com/events-presentations. An archived replay will be available for a period of 90 days after the conference.
Trxade Group, Inc.: Trxade Group to Present at March Investor Conferences
, a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience
, today announced that management will present at the following virtual investor conferences during the month of March 2021.
Suren Ajjarapu, Chief Executive Officer of Trxade Group, is scheduled to host pre-recorded virtual presentations during each of the conferences as follows and will participate in one-on-one meetings throughout the day at each event.
H.C. Wainwright Global Life Sciences Conference - Virtual
Date: March 9-10, 2021
ROTH Growth Stock Conference - Virtual
Date: March 15-17, 2021
Maxim Group Emerging Growth Conference - Virtual
DBV Technologies S.A.: DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference
DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference
DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held March 9-10, 2021.
A webcast of the presentation at the H.C. Wainwright Healthcare Conference will be available on the Investors & Media section of the Company s website beginning Tuesday, March 9
th at 7:00 a.m. ET: